NZ184634A - N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions - Google Patents

N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions

Info

Publication number
NZ184634A
NZ184634A NZ184634A NZ18463477A NZ184634A NZ 184634 A NZ184634 A NZ 184634A NZ 184634 A NZ184634 A NZ 184634A NZ 18463477 A NZ18463477 A NZ 18463477A NZ 184634 A NZ184634 A NZ 184634A
Authority
NZ
New Zealand
Prior art keywords
pyrrolidylmethyl
sulphamoyl
benzamide
dimethoxy
allyl
Prior art date
Application number
NZ184634A
Other languages
English (en)
Inventor
J Perrot
M Thominet
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of NZ184634A publication Critical patent/NZ184634A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ184634A 1976-07-19 1977-07-13 N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions NZ184634A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (1)

Publication Number Publication Date
NZ184634A true NZ184634A (en) 1978-11-13

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184634A NZ184634A (en) 1976-07-19 1977-07-13 N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions

Country Status (38)

Country Link
US (1) US4499019A (US07696358-20100413-C00002.png)
JP (1) JPS5338631A (US07696358-20100413-C00002.png)
AR (1) AR214330A1 (US07696358-20100413-C00002.png)
AT (1) AT365570B (US07696358-20100413-C00002.png)
AU (1) AU509291B2 (US07696358-20100413-C00002.png)
BE (1) BE856289A (US07696358-20100413-C00002.png)
CH (1) CH627162A5 (US07696358-20100413-C00002.png)
CS (1) CS219885B2 (US07696358-20100413-C00002.png)
CY (1) CY1036A (US07696358-20100413-C00002.png)
DD (2) DD137670A5 (US07696358-20100413-C00002.png)
DK (1) DK156646C (US07696358-20100413-C00002.png)
EG (1) EG12911A (US07696358-20100413-C00002.png)
ES (1) ES460621A1 (US07696358-20100413-C00002.png)
FI (1) FI67213C (US07696358-20100413-C00002.png)
FR (1) FR2358892A1 (US07696358-20100413-C00002.png)
GB (1) GB1539319A (US07696358-20100413-C00002.png)
GR (1) GR60836B (US07696358-20100413-C00002.png)
HK (1) HK17880A (US07696358-20100413-C00002.png)
HU (1) HU174981B (US07696358-20100413-C00002.png)
IE (1) IE46171B1 (US07696358-20100413-C00002.png)
IL (1) IL52547A (US07696358-20100413-C00002.png)
IN (1) IN146993B (US07696358-20100413-C00002.png)
LU (1) LU77782A1 (US07696358-20100413-C00002.png)
MC (1) MC1153A1 (US07696358-20100413-C00002.png)
MX (1) MX4711E (US07696358-20100413-C00002.png)
NL (1) NL174347C (US07696358-20100413-C00002.png)
NO (1) NO146598C (US07696358-20100413-C00002.png)
NZ (1) NZ184634A (US07696358-20100413-C00002.png)
OA (1) OA05704A (US07696358-20100413-C00002.png)
PH (1) PH12838A (US07696358-20100413-C00002.png)
PL (1) PL104244B1 (US07696358-20100413-C00002.png)
PT (1) PT66819B (US07696358-20100413-C00002.png)
RO (1) RO71691A (US07696358-20100413-C00002.png)
SE (1) SE425243B (US07696358-20100413-C00002.png)
SU (1) SU695556A3 (US07696358-20100413-C00002.png)
YU (1) YU40677B (US07696358-20100413-C00002.png)
ZA (1) ZA774256B (US07696358-20100413-C00002.png)
ZM (1) ZM5477A1 (US07696358-20100413-C00002.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
AU509291B2 (en) 1980-05-01
CH627162A5 (US07696358-20100413-C00002.png) 1981-12-31
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
PH12838A (en) 1979-09-05
FI67213C (fi) 1985-02-11
FI67213B (fi) 1984-10-31
DD137670A5 (de) 1979-09-19
RO71691A (ro) 1982-09-09
NO146598C (no) 1982-11-03
IE46171B1 (en) 1983-03-23
AU2702677A (en) 1979-01-18
SE7708176L (sv) 1978-01-20
ES460621A1 (es) 1978-05-01
DK156646C (da) 1990-02-05
FR2358892A1 (fr) 1978-02-17
NL174347C (nl) 1984-06-01
FI772214A (US07696358-20100413-C00002.png) 1978-01-20
SE425243B (sv) 1982-09-13
PL199723A1 (pl) 1978-04-24
PL104244B1 (pl) 1979-08-31
ATA511677A (de) 1981-06-15
PT66819B (fr) 1978-12-22
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
AR214330A1 (es) 1979-05-31
IL52547A0 (en) 1977-10-31
US4499019A (en) 1985-02-12
AT365570B (de) 1982-01-25
OA05704A (fr) 1981-05-31
NL174347B (nl) 1984-01-02
IL52547A (en) 1980-01-31
NO772530L (no) 1978-01-20
YU40677B (en) 1986-04-30
JPS554724B2 (US07696358-20100413-C00002.png) 1980-01-31
NO146598B (no) 1982-07-26
MC1153A1 (fr) 1978-04-17
JPS5338631A (en) 1978-04-08
SU695556A3 (ru) 1979-10-30
IE46171L (en) 1978-01-19
HK17880A (en) 1980-04-11
CS219885B2 (en) 1983-03-25
IN146993B (US07696358-20100413-C00002.png) 1979-10-20
NL7707982A (nl) 1978-01-23
DK326377A (da) 1978-01-20
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
EG12911A (en) 1980-12-31
MX4711E (es) 1982-08-11
DK156646B (da) 1989-09-18
GR60836B (en) 1978-08-31
HU174981B (hu) 1980-04-28
LU77782A1 (US07696358-20100413-C00002.png) 1977-10-17
PT66819A (fr) 1977-08-01
YU173977A (en) 1983-01-21
FR2358892B1 (US07696358-20100413-C00002.png) 1978-12-15

Similar Documents

Publication Publication Date Title
NZ183616A (en) Acetohydroxamic derivatives,and pharmaceutical compositions
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
PH16512A (en) N-(phenylalkylamino-alkyl)-dihydroisoquinolinones,pharmaceutical compositions and methods employing them
IL51616A0 (en) N-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazole-3-carboxamides and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
NZ184634A (en) N-(i'allyl-2-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoyl-benzamide and pharmaceutical compositions
HK27081A (en) N-(1,3,4-thiadiazol-2yl)benzamides and their use as insecticides
IL53171A (en) Substituted n-(carbamoylalkyl-carbamoylalkyl)-lactam derivatives,their preparation and pharmaceutical compositions containing them
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ186425A (en) 1,3-disubstituted ureas and 2-thioureas also pharmaceutical compositions containing them
IL53342A (en) Monocyclic -lactams,their preparation and pharmaceutical compositions containing -lactams having anitbacterial activite
NZ185996A (en) 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions
IL52270A (en) 3-(n-(2'-hydroxy-n-propyl)amino)-6-acylhydrazinopyridazinederivatives,their preparation and pharmaceutical compositions containing them
NZ183154A (en) 1,3-dihydro-1-dimethylphosphinylalkyl-3-phenylspiro-(isobenzofuran) derivatives and pharmaceutical compositions
HK12283A (en) N-(1,3,4-thiadiazol-2-4l)benzamides
GB1544041A (en) N-substituted 7-amino-1,3,5-triaza-adamantane compounds their preparation and use
NZ184908A (en) N-(2,6-dichlorophenyl)-2-aminopyrimidine and analgesic compositions